Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dystrophin pre-messenger RNA exon 53 splice motifs are specific nucleotide sequences within the DMD gene transcript that are targeted to modulate the splicing process in Duchenne muscular dystrophy (DMD) (Source: PubMed, PMID: 32955437). In patients with deletions amenable to exon 53 skipping, such as those missing exon 52, the reading frame of the mRNA is disrupted, leading to a complete lack of functional dystrophin protein (Source: NIH, MedlinePlus). Antisense oligonucleotides (ASOs) like viltolarsen and golodirsen bind to these splice motifs, masking exon 53 from the spliceosomal machinery and causing it to be excluded from the mature mRNA (Source: FDA, Vyondys 53 Prescribing Information). This exon skipping strategy restores the translational reading frame, enabling the production of a truncated but partially functional dystrophin protein similar to that found in Becker muscular dystrophy (Source: StatPearls, Duchenne Muscular Dystrophy). Clinical efficacy is primarily monitored through the quantification of dystrophin protein in muscle tissue and the assessment of motor function (Source: PubMed, PMID: 32453465). Safety considerations for drugs targeting these motifs include potential renal toxicity and infusion-related reactions (Source: FDA, Viltepso Prescribing Information).
Antisense oligonucleotide-mediated exon skipping to restore the open reading frame of the dystrophin transcript (Source: PubMed, PMID: 32955437).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dystrophin pre-messenger RNA exon 53 splice motifs (DMD exon 53).